New paper from Jun-yong Huang's lab

A new paper from Jianquan Li and others in Jun-yong Huang’s lab has been published in Cell Division, showing that M2I-1, the first small molecule identified to disrupt CDC20-MAD2 interaction, enhances the sensitivity of cancer cells to anti-mitotic drugs. 

Last modified: Tue, 18 Jun 2019 10:55:41 BST